Evidence map›Paper›PMID 30002426›Full record

ArticleScientific reports2018

Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.

Giuseppe Ferrauto, Enza Di Gregorio, Stefania Lanzardo, Laura Ciolli, Manuela Iezzi, Silvio Aime

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Cell-permeable lanthanide-platinum(IV) anti-cancer prodrugs.Dalton transactions (Cambridge, England : 2003) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Giuseppe FerrautoMolecular Imaging Center, Department of Molecular Biotechnologies and health Sciences, University of Torino, Torino, Italy. giuseppe.ferrauto@unito.it.ORCID 0000-0003-4937-6140
Enza Di GregorioMolecular Imaging Center, Department of Molecular Biotechnologies and health Sciences, University of Torino, Torino, Italy.
Stefania LanzardoDepartment of Molecular Biotechnologies and health Sciences, University of Torino, Torino, Italy.
Laura CiolliDepartment of Medicine and Aging Science, Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. D'Annunzio University, Chieti-Pescara, Italy.
Manuela IezziDepartment of Medicine and Aging Science, Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. D'Annunzio University, Chieti-Pescara, Italy.
Silvio AimeMolecular Imaging Center, Department of Molecular Biotechnologies and health Sciences, University of Torino, Torino, Italy.
University of Turin · ITUniversity of Chieti-Pescara · IT

Funding

Fondazione Italiana per la Ricerca sul Cancro (Italian Foundation for Cancer Research) triennal fellowship EDGFondazione Italiana per la Ricerca sul Cancro (Italian Foundation for Cancer Research) triennal fellowship GF
6 · The paper itself

Abstract

Prostate Cancer (PCa) is the second most common and fifth cause of cancer-related mortality in males in Western Countries. The development of innovative tools for an early, more precise and noninvasive diagnosis is a medical need. Vascular volume (Vv) and hypoxia are two of the most important tumor hallmarks. Herein, they have been assessed in TRAMP mice by using MRI. Their quantification has been carried out by injecting autologous Red Blood Cells (RBCs), ex vivo labelled with Gd-HPDO3A or Gd-DOTP complexes, respectively. Gd-labelled-RBCs are stably confined in the intravascular space, also in presence of a very leaky tumor endothelium, thus representing efficient probes for vascular space analysis. Vv enhancement and hypoxia onset have been demonstrated to be present at early stages of PCa and their expression largely increases with tumor development. Moreover, also Diffusion weighted MRI and Amide Proton Transfer MRI have been herein applied to characterize PCa. The herein applied multiparametric MRI (mpMRI) analysis allows a detailed in vivo characterization of PCa, in which each histotype and cancer stage displays a specific MRI pattern. This provides an unprecedented opportunity to feature prostate tumor, making possible a non-invasive, precise and early diagnosis, which could direct treatments towards a more personalized medicine.

Indexed as

ErythrocytesAdenocarcinomaAnimalsContrast MediaDiffusion Magnetic Resonance ImagingDisease Models, AnimalErythrocyte CountGadoliniumHeterocyclic CompoundsHumansMaleMiceMice, Inbred C57BLMice, TransgenicNeoplasm StagingOrganometallic CompoundsContrast MediaGadoliniumgadolinium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid)gadoteridolHeterocyclic CompoundsOrganometallic CompoundsOrganophosphorus Compounds

Identifiers

PMID30002426
PMCPMC6043588
OpenAlexW2829744555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.